Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
REGN-7999 by Regeneron Pharmaceuticals for Iron Deficiency Anemia: Likelihood of Approval
REGN-7999 is under clinical development by Regeneron Pharmaceuticals and currently in Phase I for Iron Deficiency Anemia. According to GlobalData,...